Skip to main content
. 2022 Sep 14;2022:5971981. doi: 10.1155/2022/5971981

Table 4.

Serum omentin (ng/ml) and NGAL (ng/ml) in different studied groups.

Markers Study groups
Healthy (N = 30) Breast cancer patients (N = 120)
Omentin-1 (ng/ml) Mean ± SD 98.4 ± 8.2 316.5 ± 293.6
Minimum 91.7 106.5
Maximum 113.2 1172.7
p value <0.001

NGAL (ng/ml) Mean ± SD 117.6 ± 15.7 488.5 ± 388
Minimum 99.5 217.8
Maximum 145.3 1917
p value <0.001